Piperidines are widely found in biologically active compounds, and accessing these N-heterocycles from pyridines is a commonly used strategy. However, this approach is challenging when pyridines are embedded in complex structures, such as those found in pharmaceutical compounds. Here, we present a sequential approach to piperidines that commences with a hydride addition to NTf-activated pyridinium salts. In this method, we combined tris(pentafluorophenyl)borane as a catalyst with a silane reducing agent to achieve 4-selective mon-reduction, and then combined it with metal-catalyzed reductions to obtain tetrahydropiperidine and piperidine derivatives. The process operates on a broad range of pyridines with various functional groups and substitution patterns, as well as on pyridine-containing drugs.
Building similarity graph...
Analyzing shared references across papers
Loading...
Josephitis et al. (Mon,) studied this question.
www.synapsesocial.com/papers/6971bdad642b1836717e24a0 — DOI: https://doi.org/10.1055/a-2784-2600
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:
Celena M. Josephitis
Andrew McNally
Synthesis
Colorado State University
Building similarity graph...
Analyzing shared references across papers
Loading...